ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas Orszulak
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orszulak, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Orszulak, T.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2004;78:476
© 2004 The Society of Thoracic Surgeons

Invited commentary

Thomas Orszulak, MD

Department of Thoracic and Cardiovascular Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA

e-mail: orszulak.thomas@mayo.edu

The first 20% of the full text of this article appears below.

The article by Locker and colleagues outlines further refinement of our knowledge and treatment of coronary artery disease. There are limitations of the study in that it is not randomized. It is a consecutive series that adds some strength to the results; however, a selection bias cannot be excluded. This selection bias is most evident in the number of vessels treated in each group . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.